Thomas H. Aldrich

Person

Ossining, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fusion polypeptides capable of activating receptors
- Patent number 10,428,135
- Issue date Oct 1, 2019
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fusion polypeptides capable of activating receptors
- Patent number 9,840,549
- Issue date Dec 12, 2017
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant cell surface capture proteins
- Patent number 9,758,592
- Issue date Sep 12, 2017
- REGENERON PHARMACEUTICALS, INC.
- Dipali Deshpande
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion polypeptides capable of activating receptors
- Patent number 8,927,233
- Issue date Jan 6, 2015
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion polypeptides capable of activating receptors
- Patent number 8,865,430
- Issue date Oct 21, 2014
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion polypeptides capable of activating receptors
- Patent number 8,597,898
- Issue date Dec 3, 2013
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion polypeptides capable of activating receptors
- Patent number 8,470,324
- Issue date Jun 25, 2013
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion polypeptides capable of activating receptors
- Patent number 8,298,532
- Issue date Oct 30, 2012
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion polypeptides capable of activating receptors
- Patent number 7,534,604
- Issue date May 19, 2009
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TIE-2 ligands, methods of making and uses thereof
- Patent number 7,063,840
- Issue date Jun 20, 2006
- REGENERON PHARMACEUTICALS, INC.
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of blocking blood vessel growth using tie-2 ligand 2
- Patent number 6,645,484
- Issue date Nov 11, 2003
- REGENERON PHARMACEUTICALS, INC.
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tie-2 ligands
- Patent number 6,433,143
- Issue date Aug 13, 2002
- REGENERON PHARMACEUTICALS, INC.
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to human TIE-2 ligands
- Patent number 6,166,185
- Issue date Dec 26, 2000
- REGENERON PHARMACEUTICALS, INC.
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tie-2 ligand 1
- Patent number 5,879,672
- Issue date Mar 9, 1999
- REGENERON PHARMACEUTICALS, INC.
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of enhancing the biological activity of Eph family ligands
- Patent number 5,747,033
- Issue date May 5, 1998
- REGENERON PHARMACEUTICALS, INC.
- Samuel Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid encoding tie-2 ligand
- Patent number 5,643,755
- Issue date Jul 1, 1997
- Regeneron Pharmaceuticals Inc.
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Assay systems for trkB neurotrophin activity
- Patent number 5,622,862
- Issue date Apr 22, 1997
- REGENERON PHARMACEUTICALS, INC.
- Stephen P. Squinto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TIE-2 ligand, and method of making
- Patent number 5,521,073
- Issue date May 28, 1996
- REGENERON PHARMACEUTICALS, INC.
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Recombinant Cell Surface Capture Proteins
- Publication number 20210009714
- Publication date Jan 14, 2021
- Regeneron Pharmaceuticals, Inc.
- DIPALI DESHPANDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fusion Polypeptides Capable Of Activating Receptors
- Publication number 20190382465
- Publication date Dec 19, 2019
- Regeneron Pharmaceuticals, Inc.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fusion Polypeptides Capable Of Activating Receptors
- Publication number 20180162924
- Publication date Jun 14, 2018
- Regeneron Pharmaceuticals, Inc.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Recombinant Cell Surface Capture Proteins
- Publication number 20180118852
- Publication date May 3, 2018
- Regeneron Pharmaceuticals, Inc.
- DIPALI DESHPANDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isolating Cells Expressing Secreted Proteins
- Publication number 20170241887
- Publication date Aug 24, 2017
- Regeneron Pharmaceuticals, Inc.
- JAMES P. FANDL
- G01 - MEASURING TESTING
Information Patent Application
Fusion Polypeptides Capable Of Activating Receptors
- Publication number 20150175676
- Publication date Jun 25, 2015
- Regeneron Pharmaceuticals, Inc.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECOMBINANT CELL SURFACE CAPTURE PROTEINS
- Publication number 20140134719
- Publication date May 15, 2014
- Regeneron Pharmaceuticals, Inc.
- DIPALI DESHPANDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOLATING CELLS EXPRESSING SECRETED PROTEINS
- Publication number 20140072980
- Publication date Mar 13, 2014
- Regeneron Pharmaceuticals, Inc.
- JAMES P. FANDL
- G01 - MEASURING TESTING
Information Patent Application
ISOLATING CELLS EXPRESSING SECRETED PROTEINS
- Publication number 20140072979
- Publication date Mar 13, 2014
- Regeneron Pharmaceuticals, Inc.
- JAMES P. FANDL
- G01 - MEASURING TESTING
Information Patent Application
FUSION POLYPEPTIDES CAPABLE OF ACTIVATING RECEPTORS
- Publication number 20130280758
- Publication date Oct 24, 2013
- Regeneron Pharmaceuticals, Inc.
- James P. Fandl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUSION POLYPEPTIDES CAPABLE OF ACTIVATING RECEPTORS
- Publication number 20130259881
- Publication date Oct 3, 2013
- Regeneron Pharmaceuticals, Inc.
- James P. Fandl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fusion Polypeptides Capable of Activating Receptors
- Publication number 20130034902
- Publication date Feb 7, 2013
- Regeneron Pharmaceuticals, Inc.
- James P. Fandl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fusion Polypeptides Capable of Activating Receptors
- Publication number 20130034553
- Publication date Feb 7, 2013
- Regeneron Pharmceuticals, Inc.
- James P. Fandl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fusion Polypeptides Capable of Activating Receptors
- Publication number 20110165650
- Publication date Jul 7, 2011
- Regeneron Pharmaceuticals, Inc.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fusion Polypeptides Capable of Activating Receptors
- Publication number 20100233803
- Publication date Sep 16, 2010
- Regeneron Pharmaceuticals, Inc.
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fusion polypeptides capable of activating receptors
- Publication number 20050158829
- Publication date Jul 21, 2005
- James P. Fandl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TIE-2 ligands, methods of making and uses thereof
- Publication number 20030166858
- Publication date Sep 4, 2003
- Samuel Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TIE-2 ligands, methods of making and uses thereof
- Publication number 20030166857
- Publication date Sep 4, 2003
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TIE-2 ligands, methods of making and uses thereof
- Publication number 20030109677
- Publication date Jun 12, 2003
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TIE-2 ligands, methods of making and uses thereof
- Publication number 20020173627
- Publication date Nov 21, 2002
- Samuel Davis
- C07 - ORGANIC CHEMISTRY

Thomas H. Aldrich

Person

Patents Grantslast 30 patents

Fusion polypeptides capable of activating receptors

Fusion polypeptides capable of activating receptors

Recombinant cell surface capture proteins

Fusion polypeptides capable of activating receptors

Fusion polypeptides capable of activating receptors

Fusion polypeptides capable of activating receptors

Fusion polypeptides capable of activating receptors

Fusion polypeptides capable of activating receptors

Fusion polypeptides capable of activating receptors

TIE-2 ligands, methods of making and uses thereof

Method of blocking blood vessel growth using tie-2 ligand 2

Tie-2 ligands

Antibodies to human TIE-2 ligands

Tie-2 ligand 1

Method of enhancing the biological activity of Eph family ligands

Nucleic acid encoding tie-2 ligand

Assay systems for trkB neurotrophin activity

TIE-2 ligand, and method of making

Patents Applicationslast 30 patents

Recombinant Cell Surface Capture Proteins

Fusion Polypeptides Capable Of Activating Receptors

Fusion Polypeptides Capable Of Activating Receptors

Recombinant Cell Surface Capture Proteins

Isolating Cells Expressing Secreted Proteins

Fusion Polypeptides Capable Of Activating Receptors

RECOMBINANT CELL SURFACE CAPTURE PROTEINS

ISOLATING CELLS EXPRESSING SECRETED PROTEINS

ISOLATING CELLS EXPRESSING SECRETED PROTEINS

FUSION POLYPEPTIDES CAPABLE OF ACTIVATING RECEPTORS

FUSION POLYPEPTIDES CAPABLE OF ACTIVATING RECEPTORS

Fusion Polypeptides Capable of Activating Receptors

Fusion Polypeptides Capable of Activating Receptors

Fusion Polypeptides Capable of Activating Receptors

Fusion Polypeptides Capable of Activating Receptors

Fusion polypeptides capable of activating receptors

TIE-2 ligands, methods of making and uses thereof

TIE-2 ligands, methods of making and uses thereof

TIE-2 ligands, methods of making and uses thereof

TIE-2 ligands, methods of making and uses thereof